Signum Biosciences is a private biotech company founded in 2003 from technologies developed by Dr. Jeffry Stock at Princeton University. With over 15 years of developing multiple ingredients and botanical extracts from discovery to fully formulated skin-care products that are on the market, Signum possesses the ability to streamline your research and product development.
We specialize in producing customized claim support and dermatological efficacy testing to provide clients with robust scientific data needed to substantiate product claims and/or compare head to head versus competitors. We work with clients ranging from multi-national companies to virtual biotech startups, all projects are welcomed. We have highly trained scientists who can tailor a research plan to fit your requirements be it efficacy, safety, regulatory or scientific marketing. Whether you are early in discovery phase, development, clinical stage, or ready to commercialize your products, Signum can provide the following services to aid you on your product development path.
- Standard assays to determine activity profile
- Safety and regulatory support
- Customized screening
- Topical formulation development, stability and dermal penetration studies
- Scientific marketing and peer-reviewed publishing of results
- Botanical extraction, characterization and manufacturing
- Compound synthesis and manufacturing
Signum is the solution to optimize your R&D screening, product development and customized research at a reduced cost compared to larger CRO’s. We provide superior service to differentiate your product, so contact us today. Our discussions will provide the scientific excellence and quality your product deserves.
"I have been using Epicutis for about a month and it has transformed my dry, sun-damaged skin. My skin feels and looks so much more youthful and healthy." - Katy
|Human Epidermal Keratinocytes (NHEKs) or Human Reconstructed Epidermis (EpiDerm™)
|DNA pyrimidine dimers
|Peripheral Blood Mononuclear Cells (PBMC)
|Human Dermal Microvascular Endothelial Cells (HDMECs)
|MTS Viability, Cytokine ELISA
|anti-microbial peptide (LL-37)
|Human Epidermal Keratinocytes (NHEKs)
|C. acnes, PGN
|Human Reconstructed Cornea (EpiOcular™)